2015 29 Jun
The Roche test enables healthcare professionals to identify patients with a suspected heart attack in the pre-hospital setting, helping ensure correct diagnosis and immediate, appropriate intervention.Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that its improved CARDIAC point-of-care Troponin T test for the cobas h 232 system is now available... Read more
JOIN OUR MANAGEMENT COMMUNITY
Point-of-Care Ultrasound Takes to the Skies
EHAAT crew members and the SonoSite team with the new helicopterSonoSite... Read more
Sphere Medical Proxima™ Bedside Blood Gas Monitoring System Compatible with Philips IntelliVue
As a patient dedicated system, Proxima is always connected to the patient... Read more
UPMC, considers opportunities to join Moscow International Medical Cluster
UPMC, world-renowned health care provider from USA, arrived on official... Read more
Philips Speeds Up Research and Biomarker Discovery with Major Upgrade
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health techno... Read more
Clinical Trials Demonstrate Benefits of iFR Compared to FFR
The DEFINE FLAIR and iFR Swedeheart studies establish that iFR offers a... Read more
EOS imaging Appoints Mike Lobinsky to Newly Created Position of President, North America
Proven executive experienced in orthopedics and medical imaging will lead... Read more
Solange Peters Elected ESMO President 2020-2021
ESMO, the leading European professional organisation for medical oncology... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
Primex Pharmaceuticals Appoints Jostein Davidsen and Angelo Colombo as Board Members
Swiss pharmaceutical group Primex Pharmaceuticals AG announces new board... Read more
New President of Sectra’s Secure Communications Business Area
Simo Pykälistö, currently CFO and Executive Vice President of Sectra AB... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY